Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.44 |
| ▸ | CNR1 | P21554 | 6/20 | 0.40 |
| ▸ | CNR2 | P34972 | 3/20 | 0.40 |
| ▸ | ESR1 | P03372 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | BCR | P11274 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.39 |
| ▸ | TUBB | P07437 | 1/20 | 0.39 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.39 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.39 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10296724 | 1.00 | AHR (0.48) | AHRCYP1A1CYP1B1CNR1CNR2 | |
| SCHEMBL10296739 | 0.90 | AHR (0.57) | AHRCYP1A1CYP1B1CNR1CNR2 | |
| SCHEMBL31185805 | 0.85 | AHR (0.58) | AHRCYP1A1CYP1B1ESR1CYP1A2 | |
| SCHEMBL29084151 | 0.83 | TNNC1 (0.42) | — | |
| SCHEMBL29084153 | 0.83 | TNNC1 (0.42) | — | |
| SCHEMBL25985066 | 0.78 | CYP1A1 (0.47) | CYP1A1CYP1A2ALOX5CYP19A1 | |
| SCHEMBL6269670 | 0.78 | AHR (0.51) | AHRCYP1A1CYP1B1CNR1CNR2 | |
| Hexane SCHEMBL28393141 | 0.77 | ALDH1A1 (0.52) | AHRCYP1A1CYP1B1CNR1CNR2 | |
| SCHEMBL3299520 | 0.77 | RELA (0.53) | CYP1A1CYP1B1CYP1A2CYP19A1NQO2 | |
| SCHEMBL17469176 | 0.77 | CYP1A1 (0.50) | AHRCYP1A1CYP1B1ESR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120172339-A1 | ANGIOGENIC RESORCINOL DERIVATIVES | NORTHEASTERN UNIVERSITY (US) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172339-A1 | ANGIOGENIC RESORCINOL DERIVATIVES | CNR1, CNR2, KDR | AHR 943/4885CYP1A1 1242/4885CYP1B1 631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.